Medpace Holdings Company Insiders
MEDP Stock | USD 341.82 15.73 4.82% |
Medpace Holdings' insiders are aggressively selling. The analysis of insiders' sentiment of trading Medpace Holdings stock suggests that virtually all insiders are panicking at this time. Medpace Holdings employs about 5.9 K people. The company is managed by 14 executives with a total tenure of roughly 19 years, averaging almost 1.0 years of service per executive, having 421.43 employees per reported executive.
Susan Burwig President Senior Vice President - Operations |
Medpace Holdings' Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-07-26 | Josh Gottheimer | Disposed @ 381.47 | |||
2024-06-21 | Josh Gottheimer | Disposed @ 404.03 | |||
2024-05-28 | August J Troendle | Disposed 5695 @ 395.49 | View | ||
2024-05-24 | August J Troendle | Disposed 3987 @ 395.22 | View | ||
2024-05-22 | August J Troendle | Disposed 55 @ 400 | View | ||
2024-05-08 | August J Troendle | Disposed 4782 @ 400.58 | View | ||
2024-04-29 | August J Troendle | Disposed 15102 @ 400.69 | View | ||
2024-03-15 | Susan E Burwig | Disposed 102 @ 403 | View | ||
2024-03-14 | Ashley M Keating | Disposed 250 @ 409.87 | View | ||
2024-03-08 | August J Troendle | Disposed 25000 @ 408.71 | View | ||
2024-03-06 | August J Troendle | Disposed 100000 @ 412.98 | View | ||
2024-02-20 | Medpace Investors, Llc | Disposed 13988 @ 386.39 | View | ||
2024-02-16 | Medpace Investors, Llc | Disposed 50000 @ 391.75 | View | ||
2024-01-24 | Josh Gottheimer | Disposed @ 296.55 | |||
2023-12-14 | Susan E Burwig | Disposed 10391 @ 304.15 | View | ||
2023-12-01 | Medpace Investors, Llc | Disposed 24039 @ 273.26 | View | ||
2023-11-30 | August J Troendle | Disposed 7871 @ 272.18 | View | ||
2023-11-29 | Medpace Investors, Llc | Disposed 21257 @ 272.66 | View | ||
2023-11-28 | August J Troendle | Disposed 21833 @ 273.66 | View | ||
2023-11-27 | Medpace Investors, Llc | Disposed 25000 @ 276.1 | View |
Monitoring Medpace Holdings' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Medpace |
Medpace Holdings' Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Medpace Holdings' future performance. Based on our forecasts, it is anticipated that Medpace will maintain a workforce of slightly above 5900 employees by December 2024.Medpace Holdings' latest congressional trading
Congressional trading in companies like Medpace Holdings, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Medpace Holdings by those in governmental positions are based on the same information available to the general public.
2024-08-15 | Representative Josh Gottheimer | Acquired Under $15K | Verify | ||
2024-07-09 | Representative Josh Gottheimer | Acquired Under $15K | Verify |
Medpace Holdings Management Team Effectiveness
The company has return on total asset (ROA) of 0.1431 % which means that it generated a profit of $0.1431 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.5408 %, meaning that it created $0.5408 on every $100 dollars invested by stockholders. Medpace Holdings' management efficiency ratios could be used to measure how well Medpace Holdings manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/22/2024, Return On Tangible Assets is likely to grow to 0.31. Also, Return On Capital Employed is likely to grow to 0.48. At this time, Medpace Holdings' Total Current Liabilities is relatively stable compared to the past year. As of 11/22/2024, Non Current Liabilities Total is likely to grow to about 182.2 M, while Liabilities And Stockholders Equity is likely to drop slightly above 1.3 B.As of 11/22/2024, Net Income Applicable To Common Shares is likely to grow to about 296.3 M, while Common Stock Shares Outstanding is likely to drop slightly above 29 M.
Medpace Holdings Workforce Comparison
Medpace Holdings is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 307,854. Medpace Holdings claims roughly 5,900 in number of employees contributing just under 2% to equities under Health Care industry.
Medpace Holdings Profit Margins
The company has Profit Margin (PM) of 0.18 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.21 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.21.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.4 | 0.2781 |
|
| |||||
Operating Profit Margin | 0.12 | 0.1786 |
|
|
Medpace Holdings Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Medpace Holdings insiders, such as employees or executives, is commonly permitted as long as it does not rely on Medpace Holdings' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Medpace Holdings insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-12-01 | 1.0 | 1 | 1 | 7,500 | 7,500 |
2024-09-01 | 1.7143 | 12 | 7 | 144,162 | 62,112 |
2024-06-01 | 0.4737 | 9 | 19 | 5,930 | 159,880 |
2024-03-01 | 0.2083 | 10 | 48 | 60,178 | 1,801,750 |
2023-12-01 | 0.2188 | 7 | 32 | 8,627 | 670,179 |
2023-09-01 | 0.3529 | 6 | 17 | 45,911 | 724,687 |
2023-06-01 | 0.8333 | 10 | 12 | 18,293 | 507,679 |
2023-03-01 | 3.0 | 9 | 3 | 5,853 | 280.00 |
2022-12-01 | 0.6667 | 6 | 9 | 24,247 | 60,260 |
2022-03-01 | 1.1429 | 8 | 7 | 308,993 | 258,564 |
2021-12-01 | 0.0833 | 5 | 60 | 23,750 | 949,378 |
2021-09-01 | 0.0411 | 3 | 73 | 3,500 | 613,290 |
2021-06-01 | 0.3125 | 15 | 48 | 155,788 | 501,658 |
2021-03-01 | 0.5714 | 12 | 21 | 384,694 | 664,693 |
2020-12-01 | 0.4074 | 11 | 27 | 160,641 | 758,817 |
2020-09-01 | 0.0506 | 4 | 79 | 17,710 | 2,063,428 |
2020-06-01 | 4.0 | 8 | 2 | 30,184 | 7,036 |
2020-03-01 | 2.3333 | 14 | 6 | 283,175 | 53,328 |
2019-12-01 | 0.5556 | 5 | 9 | 5,167 | 58,294 |
2019-09-01 | 3.7143 | 26 | 7 | 712,406 | 28,022 |
2019-06-01 | 1.8333 | 11 | 6 | 347,521 | 108,454 |
2019-03-01 | 0.0303 | 1 | 33 | 77,417 | 836,528 |
2018-09-01 | 0.24 | 6 | 25 | 331,439 | 16,257,565 |
2018-06-01 | 1.5 | 3 | 2 | 24,381 | 6,000,000 |
2017-06-01 | 1.25 | 5 | 4 | 51,753 | 23,058,139 |
2016-09-01 | 1.8333 | 11 | 6 | 1,006,516 | 118,517 |
Medpace Holdings Notable Stakeholders
A Medpace Holdings stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Medpace Holdings often face trade-offs trying to please all of them. Medpace Holdings' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Medpace Holdings' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Susan Burwig | Senior Vice President - Operations | Profile | |
Kevin Brady | CFO Treasurer | Profile | |
Brandon Ebken | Chief Officer | Profile | |
August MD | Chairman CEO | Profile | |
Stephen JD | General Officer | Profile | |
Stephen Ewald | General Counsel, Corporate Secretary | Profile | |
Todd Meyers | Vice Marketing | Profile | |
Reinilde MD | Chief Department | Profile | |
Weimin MS | VP Biometrics | Profile | |
Daniel OLeary | VP Department | Profile | |
John MBA | Senior Unit | Profile | |
MA BSN | Executive Operations | Profile | |
CPA BBA | President | Profile | |
Lauren Morris | Associate Relations | Profile |
About Medpace Holdings Management Performance
The success or failure of an entity such as Medpace Holdings often depends on how effective the management is. Medpace Holdings management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Medpace management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Medpace management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.30 | 0.31 | |
Return On Capital Employed | 0.46 | 0.48 | |
Return On Assets | 0.17 | 0.18 | |
Return On Equity | 0.51 | 0.53 |
Medpace Holdings Workforce Analysis
Traditionally, organizations such as Medpace Holdings use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Medpace Holdings within its industry.Medpace Holdings Manpower Efficiency
Return on Medpace Holdings Manpower
Revenue Per Employee | 319.6K | |
Revenue Per Executive | 134.7M | |
Net Income Per Employee | 47.9K | |
Net Income Per Executive | 20.2M |
Additional Tools for Medpace Stock Analysis
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.